US Broker Ratings

BeOne Medicines Ltd. (ONC) Stock Analysis: Strong Buy Ratings and 36% Upside Potential

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, has captured the attention of investors with its promising growth metrics and robust pipeline of..

Elanco Animal Health (ELAN) Stock Analysis: Navigating a 23% Potential Upside in the Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector, has garnered significant attention in the investment community due to its comprehensive portfolio..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a 25% Potential Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands as a formidable player in the biotechnology sector, with a market capitalization of $7.95 billion. Based in San Diego, California,..

Guardant Health, Inc. (GH) Stock Analysis: Unlocking a 45.36% Potential Upside in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) presents a compelling opportunity for investors looking to tap into the burgeoning field of precision oncology. As a key player in..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Unpacking Growth Potential and Analyst Consensus

Medpace Holdings, Inc. (NASDAQ: MEDP) has established itself as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 107.60% Upside Potential in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy player in the biotechnology sector, with a specialization in the discovery, development, and commercialization of innovative therapeutic..

Regencell Bioscience Holdings L (RGC): An Investor Outlook on the Hong Kong-Based TCM Innovator

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), has captured the attention of the healthcare sector, particularly with its..

Nuvalent, Inc. (NUVL) Stock Analysis: Analyst Consensus Projects a Remarkable 44% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the attention of investors in the biotechnology sector, thanks to its promising drug pipeline and striking analyst ratings. Headquartered in..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Its 9.17% Potential Upside and Market Position

Illumina, Inc. (NASDAQ: ILMN), a powerhouse in the diagnostics and research sector of the healthcare industry, stands as a beacon of innovation with its advanced sequencing..

ADMA Biologics Inc (ADMA) Stock Analysis: Strong Growth Potential with 66.77% Upside

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is attracting significant attention from investors due to its robust growth metrics and promising..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: A 54% Upside Potential Awaits

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent name in the biotechnology sector, is capturing investor attention with its robust potential upside of 54.23%. Headquartered in West..

Alkermes plc (ALKS) Stock Analysis: A 52.45% Potential Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, is a dynamic player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings Propel Potential Upside of 46%

HealthEquity, Inc. (NASDAQ: HQY), a key player in the healthcare sector, has captured investor attention with its robust growth potential and favorable analyst ratings. Based in..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Impressive 37% Upside Potential Amid Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with its promising growth trajectory in the biotechnology sector. Specializing in novel therapies for central..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 40% Upside Potential in the Healthcare Sector

Merit Medical Systems, Inc. (NASDAQ: MMSI) has captured the attention of investors with its impressive growth trajectory and notable potential upside. As a key player in..

ICON plc (ICLR)

⚠️ No article content returned.

..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Biotech Giant’s Challenges and Opportunities

Moderna, Inc. (MRNA), a titan in the biotechnology sector, has captured global attention with its groundbreaking work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts,..

Baxter International Inc. (BAX) Stock Analysis: Evaluating the 22% Potential Upside Amid Market Challenges

For investors keen on the healthcare sector, Baxter International Inc. (NYSE: BAX) presents an intriguing opportunity with its current valuation and potential upside. As a stalwart..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 21.75% Potential Upside Amidst Strong Buy Ratings

As a stalwart in the healthcare sector, Abbott Laboratories (NYSE: ABT) stands out with its diverse product portfolio and robust market presence. With a market capitalization..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 22% Potential Upside Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is attracting investor attention with a compelling potential upside of 22.35%. Headquartered in Dublin,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds